1 / 17

Chapter 11

Chapter 11. Practical Applications of Immunology. Vaccine History. Variolation: Inoculation of smallpox into skin (18th century). Vaccination: Inoculation of cowpox into skin. Herd immunity results when most of a population is immune to a disease.

kynan
Télécharger la présentation

Chapter 11

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chapter 11 Practical Applications of Immunology

  2. Vaccine History • Variolation: Inoculation of smallpox into skin (18th century). • Vaccination: Inoculation of cowpox into skin. • Herd immunity results when most of a population is immune to a disease.

  3. Principal Vaccines Used in the United States to Prevent Bacterial Diseases in Humans • DtaP • Diphtheria: Purified diphtheria toxoid • Pertussis: Acellular fragments of B. pertussis • Tetanus: Purified tetanus toxoid • Meningococcal meningitis: Purified polysaccharide from N. meningitidis • Haemophilus influenzae type b meningitis: Polysaccharides conjugated with protein • Pneumococcal conjugate vaccine: S. pneumoniae antigens conjugated with protein

  4. Principal Vaccines Used in the United States to Prevent Viral Diseases in Humans • Smallpox: Live vaccinia virus • Poliomyelitis: Inactivated virus • Rabies: Inactivated virus • Hepatitis A: Inactivated virus • Influenza: Inactivated or attenuated virus • Measles: Attenuated virus • Mumps: Attenuated virus • Rubella: Attenuated virus • Chickenpox: Attenuated virus • Hepatitis B: Antigenic fragments (recombinant vaccine)

  5. Monoclonal Antibodies (Mabs) • Alemtuzumab: For leukemia • Infliximab: For Crohn’s disease • Rituximab: For non-Hodgkin’s lymphoma • Trastuzumab: Herceptin for breast cancer • Basiliximab and daclizumab: Block IL–2, immunosuppresives for transplants • Palivizumab: Treatment of RSV

  6. Monoclonal Antibodies Figure 18.2

  7. Monoclonal Antibodies • Immunotoxins: Mabs conjugated with a toxin to target cancer cells. • Chimeric mabs: Genetically modified mice that produce Ab with a human constant region. • Humanized mabs: Mabs that are mostly human, except for mouse antigen-binding. • Fully human antibodies: Mabs produced from a human gene on a mouse.

  8. Precipitation Reactions • Involve soluble antigens with antibodies. Figure 18.4

  9. Agglutination Reactions • Involve particulate antigens and antibodies. • Antigens may be • On a cell (direct agglutination). • Attached to latex spheres (indirect or passive agglutination). Figure 18.5

  10. Antibody Titer • Is the concentration of antibodies against a particular antigen. Figure 18.6

  11. Viral Hemagglutination • Hemagglutination involves agglutination of RBCs. • Some viruses agglutinate RBCs in vitro. Figure 18.8

  12. Viral Hemagglutination-Inhibition • Hemagglutination involves agglutination of RBCs. • Some viruses agglutinate RBCs in vitro. • Antibodies prevent hemagglutination. Figure 18.9b

  13. Neutralization Reactions • Eliminate the harmful effect of a virus or exotoxin. Figure 18.9b

  14. Complement Fixation Test Figure 18.10 (1 of 2)

  15. Complement Fixation Test Figure 18.10 (2 of 2)

  16. Fluorescent Antibody Techniques (Direct) Figure 18.11a

  17. Fluorescent Antibody Techniques (Indirect) Figures 18.11b, 3.6b

More Related